Meribank Biotech Co., Ltd (TPEX:4724)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
16.60
-0.40 (-2.35%)
Jun 26, 2025, 1:43 PM CST
-56.60%
Market Cap 1.49B
Revenue (ttm) 366.43M
Net Income (ttm) -94.71M
Shares Out 87.98M
EPS (ttm) -1.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 41,431
Average Volume 190,379
Open 16.50
Previous Close 17.00
Day's Range 16.50 - 17.10
52-Week Range 13.90 - 46.30
Beta 0.03
RSI 51.85
Earnings Date Aug 8, 2025

About Meribank Biotech

Meribank Biotech Co., Ltd researches, develops, manufactures, and stores mesenchymal stem cells in Taiwan. The company engages in the storage of placental umbilical cord mesenchymal stem cells, cord blood hematopoietic stem cells, and immune cells. It also provides cell cryopreservation services. Meribank Biotech Co., Ltd was founded in 2013 and is based in Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 142
Stock Exchange Taipei Exchange
Ticker Symbol 4724
Full Company Profile

Financial Performance

In 2024, Meribank Biotech's revenue was 366.43 million, an increase of 56.37% compared to the previous year's 234.34 million. Losses were -94.71 million, -24.44% less than in 2023.

Financial Statements

News

There is no news available yet.